Novo Nordisk A/S - Share repurchase programme


Bagsværd, Denmark, 05 December 2016 - On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 3 February 2016. 

Under the programme initiated 28 October 2016, Novo Nordisk will repurchase B shares for an amount up to DKK 4.5 billion in the period from 28 October 2016 to 31 January 2017.

Since the announcement as of 28 November 2016, the following transactions have been made under the programme:

  Number of
B shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement 6,802,101   1,572,674,476
28 November 2016 322,500 229.10 73,885,621
29 November 2016 326,061 230.45 75,140,977
30 November 2016 280,000 236.37 66,184,174
1 December 2016 338,491 237.02 80,228,600
2 December 2016 305,000 236.19 72,036,725
Accumulated under the programme 8,374,153   1,940,150,571

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

With the transactions stated above, Novo Nordisk owns a total of 41,473,135 B shares of DKK 0.20, corresponding to 1.6% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,550,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 3 February 2016. As of 2 December 2016, Novo Nordisk has repurchased a total of 39,549,490 B shares equal to a transaction value of DKK 12,439,909,017.

Further information

Media:    
Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
     
Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com
Hanna Ögren +45 3075 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

Company announcement No 85 / 2016


Attachments

CA161205_ShareRepurchase_UK